ClinicalTrials.gov
public full text
Public Domain
A Trial of Ipatasertib in Combination With Atezolizumab
This is a single centre, proof-of-concept phase I trial of atezolizumab in combination with ipatasertib. There are two parts to this study, the dose escalation phase (Part A) and the dose expansion phase (Part B). Part A, will determine the maximum tolerated dose (MTD) and recommended Phase II dose (RP2D). This will be followed by the Part B dose expansion phase to further characterise the safety and tolerability and to assess the pharmacodynamic activity of the combination.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma#810836
- Nemtabrutinib, Bortezomib, and Rituximab for WM#1151745
- A Multiple-Dose Study of Intravenous BNZ132-1-40 in Healthy Adult Subjects#888562
- Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of APB-R3#866850
- A Study of PRA052 in Healthy Volunteers#888441
Record · ID 1100759
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive